Catalyst Pharmaceuticals Inc (CPRX) Q4 2024: Everything You Need To Know Ahead Of Earnings [Yahoo! Finance]
Catalyst Pharmaceuticals, Inc. (CPRX)
Last catalyst pharmaceuticals, inc. earnings: 3/16 05:26 pm
Check Earnings Report
US:NASDAQ Investor Relations:
ir.catalystpharma.com
Company Research
Source: Yahoo! Finance
The consensus estimate for Q4 2024 revenue is $134.20 million, and the earnings are expected to come in at $0.33 per share. The full year 2024's revenue is expected to be $484.10 million, and the earnings are expected to be $1.20 per share. More detailed estimate data can be found on the Forecast page Catalyst Pharmaceuticals Inc ( NASDAQ:CPRX ) Estimates Trends Warning! GuruFocus has detected 3 Warning Sign with CPRX. Revenue estimates for Catalyst Pharmaceuticals Inc ( NASDAQ:CPRX ) have increased from $484.03 million to $484.10 million for the full year 2024. For 2025, revenue estimates have declined from $572.47 million to $557.33 million over the past 90 days. Earnings estimates for Catalyst Pharmaceuticals Inc ( NASDAQ:CPRX ) have remained flat at $1.20 per share for the full year 2024. However, for 2025, earnings estimates have declined from $1.57 per share to $1.43 per share over the past 90 days. Catalyst Pharmaceuticals Inc ( NASDAQ:CPRX ) Reported History In the p
Show less
Read more
Impact Snapshot
Event Time:
CPRX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
CPRX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
CPRX alerts
High impacting Catalyst Pharmaceuticals, Inc. news events
Weekly update
A roundup of the hottest topics
CPRX
News
- Catalyst Pharmaceuticals (NASDAQ:CPRX) had its "buy (b-)" rating reaffirmed by analysts at <a style="font-weight:bold" href="https://weissratings.com/">Weiss Ratings</a>.MarketBeat
- Assessing Catalyst Pharma After 600% Surge and Rare Disease Expansion in 2025 [Yahoo! Finance]Yahoo! Finance
- Catalyst Pharmaceuticals Stock Gets Relative Strength Rating Lift [Yahoo! Finance]Yahoo! Finance
- BioFlorida Fuels Innovation: Awards $90,000 in Annual Pitch Competition [Yahoo! Finance]Yahoo! Finance
- Catalyst Pharmaceuticals to Participate in the 44th Annual J.P. Morgan Healthcare ConferenceGlobeNewswire
CPRX
Earnings
- 11/5/25 - Beat
CPRX
Sec Filings
- 12/16/25 - Form 4
- 12/12/25 - Form 144
- 12/10/25 - Form 4
- CPRX's page on the SEC website